WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Candel Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CADL annual revenue was $0.0, with N/A growth year-over-year.

CADL revenue history

Current Revenue
$0.0
Current Earnings
-$55.2M
Current Profit Margin
0%

Be the first to know when CADL announces revenue.

CADL Revenue History By Year

CADL Yearly RevenueCADL RevenueCADL ChangeCADL Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Candel Therapeutics Revenue FAQ

What was CADL's revenue last quarter?

Candel Therapeutics (NASDAQ: CADL) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Candel Therapeutics's revenue was $0.00.

What was Candel Therapeutics's revenue in 2024?

Candel Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Candel Therapeutics make in a day?

Based on Candel Therapeutics annual revenue for the past five years, CADL makes an average of $0.00 per day.

What was Candel Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Candel Therapeutics's revenue has grown null year over year. Candel Therapeutics's revenue in the past year totaled $0.00.

How much does Candel Therapeutics make in a year?

Candel Therapeutics's revenue by year for the past five years is:
  • Candel Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Candel Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Candel Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Candel Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Candel Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.